IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Agile Therapeutics Inc (0AL0)

CUSIP: 00847L308 | QT | 24 institutional holders

Quarters

Q1 2024Q4 2023Q3 2023Q2 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2024

Investor AB1,754
0.0% of portfolio›$596
StyleTurnoverLocationFiled
Investor AB
1,754$5960.0%CoreVery LowStockholm, Sweden2024-05-15